Ozsoy, Zehra http://orcid.org/0000-0002-4534-4929
Ozdemir, Adem
Ekici, Mustafa
Bilgin, Emre
Kılıc, Levent
Kiraz, Sedat
Sarıbas, Zeynep
Sener, Burçin
Karadag, Omer
Article History
Received: 27 February 2023
Accepted: 22 March 2023
First Online: 1 April 2023
Declarations
:
: EB received honorary from AbbVie, Novartis, and UCB-Pharma. SK received honorary from AbbVie, Amgen, Johnson, and Johnson, MSD, Novartis, Pfizer, Roche, and UCB-Pharma. OK received honorary from AbbVie, Aristea, Roche, Novartis, Viela-Bio, Zenas Biopharma, Abdi İbrahim, Celltrion, UCB-Pharma, and Menarini. All of the other authors have declared no conflicts of interest.
: Ethical approval was obtained from Hacettepe University Institutional Review Board (GO21/595, 04/05/2021).
: Written informed consent was obtained from each patient regarding the use of clinical data for research purposes. The study was in accordance with the 2013 amendment of the Helsinki declaration.